News

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
Removing EPO signalling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
In regenerative science, B7-33's potential to influence fibroblast activity and collagen turnover suggests possible implications for tissue repair and wound healing. Given that fibrosis is often a ...
Researchers at Mayo Clinic's Center for Individualized Medicine have discovered a rare genetic variant that can directly ...
A new review published in Genes & Diseases highlights the transformative role of microRNAs (miRNAs) in regulating and potentially reversing adipose tissue fibrosis, a condition closely linked to ...
Ferroptosis plays an essential role in chronic liver diseases, and cyclooxygenase-2 (COX-2) affects liver fibrosis through multiple mechanisms. + ...
Ferroptosis plays an essential role in chronic liver diseases, and cyclooxygenase-2 (COX-2) affects liver fibrosis through multiple mechanisms ...
Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...
Naringenin is a Potential Immunomodulator for Inhibiting Liver Fibrosis by Inhibiting the cGAS-STING Pathway ... Interaction between Its Chemical Composition and the Cell-signaling Pathways Involved ...
As it advances, excessive fibrosis or buildup ... sought a way to block this pathway. They found a potential solution in Cilengitide, a drug that disrupts integrin signaling.